Jacob P. Wagner

A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with <i>ROS1</i> -Rearranged Lung Cancer

Alexander Drilon, Romel Somwar, Jacob P. Wagner et al. · Clinical Cancer Research · 2015 · 165 citations · Full text

Structural insight into selectivity and resistance profiles of ROS1 tyrosine kinase inhibitors

Monika A. Davare, Nadeem A. Vellore, Jacob P. Wagner et al. · Proceedings of the National Academy of Sciences · 2015 · 117 citations · Full text

Rare but Recurrent ROS1 Fusions Resulting From Chromosome 6q22 Microdeletions are Targetable Oncogenes in Glioma

Monika A. Davare, Jacob J. Henderson, Anupriya Agarwal et al. · Clinical Cancer Research · 2018 · 57 citations · Full text

Identifying and Quantifying Heterogeneity in High Content Analysis: Application of Heterogeneity Indices to Drug Discovery

Albert Gough, Ning Chen, Tong Ying Shun et al. · PLoS ONE · 2014 · 55 citations · Full text

Pharmaceutical Research, Engineering, Hit Identification +24

High expression of orphan nuclear receptor NR4A1 in a subset of ovarian tumors with worse outcome

Evan R. Delgado, M.M. Boisen, Robin Laskey et al. · Gynecologic Oncology · 2016 · 31 citations · Full text

Worse Outcome, Medicine, High Expression +8